Development of interest of pulmonary hypertension in the Czech Republic

Czech version

Authors: Pavel Jansa
Authors‘ workplace: Centrum pro plicní hypertenzi II. interní kliniky kardiologie a angiologie 1. LF UK a VFN Praha, přednosta prof. MUDr. Aleš Linhart, DrSc.
Published in: Vnitř Lék 2014; 60(4): 271-274
Category: 60th Birthday - prof. MUDr. Petr Widimský, DrSc., FESC, FACC

Overview

Development of clinical interest on the pulmonary hypertension is associated with the development of cardiac catheterization. The first measurement of cardiac output during right heart catheterization was performed by Otto Klein, who worked at the German University in Prague right after Forssmann´s pioneering act. The invention of the floating balloon catheter is connected with the name of William Ganz, who was born in Košice and studied medicine in Prague. Some medical centres in Prague, known as Prague School of Pulmonary Circulation have dedicated to the issue of pulmonary hypertension since the 60s of last century. From their initiative was established the European Society of Breathing Pathophysiology and between the year 1969 and 1999 were regularly held in Prague international conferences dedicated to pulmonary circulation. In clinical practice has dominated interest on treatable forms of chronic pulmonary hypertension – pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) in past 15 years. Therapy of PAH patients is concentrated in 3 specialized centres in the Czech Republic. The care of CTEPH patients is provided in Cardiocentre of General Faculty Hospital in Prague. Surgical treatment is provided to Slovak patients as well.

Key words:
chronic thromboembolic pulmonary hypertension – heart catheterization – Prague School of pulmonary circulation – pulmonary hypertension – pulmonary arterial hypertension

Sources

1. Jansa P, Popelova J, Al-Hiti H et al. Chronická plicní hypertenze. Doporučený diagnostický a léčebný postup České kardiologické společnosti, 2010. Cor Vasa 2011; 53(3): 169–182.

2. Riedel M. Dějiny kardiologie. Galén: Praha 2009. ISBN 9788072626144.

3. Romberg E. Ueber Sklerose der Lungen arterie. Dtsch Archiv Klin Med 1891; 48: 197–206.

4. Dresdale DT, Schultz M, Michtom RJ. Primary pulmonary hypertension: I. Clinical and hemodynamic study. Am J Med 1951; 11(6): 686–705.

5. Chatterjee K. The Swan-Ganz catheters: past, present, and future. A viewpoint. Circulation 2009; 119(1): 147–152.

6. Hatano E, Strasser T(eds). Primary pulmonary hypertension: report on a WHO meeting, Geneva, 15–17 October, 1973. World Health Organization: Geneva 1975. ISBN: 9242560448.

7. Simonneau G, Galie N, Rubin LJ et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004; 43(12 Suppl S): S5- S12.

8. Galie N, Hoeper MM, Humbert M et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. The task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009; 30(20): 2493–2537.

9. Hoeper MM, Bogaard HJ, Condliffe R et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol 2013; 62(Suppl 25): D42-D50.

10. Widimský J. Historie mezinárodních sympózií o plicní cirkulaci. Cor Vasa 1995; 37(1–3): K33-K37.

11. Jansa P, Susa Z, Aschermann M. Centrum primární plicní hypertenze – naše první zkušenosti. Cor Vasa 2000; 42(10): 516–517.

12. Jansa P, Jarkovsky J, Al-Hiti H et al. Epidemiology and long-term survival of pulmonary arterial hypertension in the Czech Republic: a retrospective analysis of a nationwide registry. HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/?term=Jansa+P%2C+Jarkovsky+J%2C+Al-Hiti+H+et+al.+Epidemiology+and+long-term+survival+of+pulmonary+arterial+hypertension+in+the+Czech" o "BMC pulmonary medicine." BMC Pulm Med 2014; 14:45. Dostupné z DOI: <http://doi: 10.1186/1471-2466-14-45>.

13. Jansa P, Becvar R, Ambroz D et al. Pulmonary Arterial Hypertension Associated with Systemic Sclerosis in the Czech Republic. Clin Rheumatol 2012; 31(3): 557–561.

14. Riedel M, Staněk V, Widimský J et al. Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest 1982; 81(2): 151–158.

15. Lindner J, Jansa P, Kunstyr J et al. Implementation of a new programme for the surgical treatment of CTEPH in the Czech Republic-Pulmonary endarterectomy. Thorac Cardiovasc Surg 2006; 54(8): 528–531.

16. Reichenbach A, Al-Hiti H, Malek I et al. The effects of phosphodiesterase 5 inhibition on hemodynamics, functional status and survival in advanced heart failure and pulmonary hypertension: a case-control study. Int J Cardiol 2013; 168(1): 60–65.